ArrowMark Partners
Overview
ArrowMark Partners is an employee-owned investment management firm that focuses on niche and less efficient market segments in public and private credit, equity, leveraged loans, and middle-market commercial real estate finance.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Poplar Therapeutics | Mar 2026 | Series A Extension | Co-investor |
| Skymerse | Feb 2026 | Series C | Co-investor |
| Skyryse | Feb 2026 | Series C | Co-investor |
| Poplar Therapeutics | Jan 2026 | Series A | Co-investor |
| Arbor Biotechnologies | Mar 2025 | Series C | Co-investor |
Key People
Brian Schaub
Partner, Portfolio Manager
Karen Reidy
Partner
Robin Beery
Partner
Mark Godfrey
Director, Investor Relations
Chris Dunne
Principal - Business Development And Client Engagement
George Braun
Principal
Logan Heidmann
Principal Investments - Commercial Real Estate
Rick Grove
Principal Compliance Officer
Timothy J. Beresford
Principal
Chad Meade
Portfolio Manager
Clayton Freeman
Portfolio Manager
Clint Chafin
Portfolio Manager
Maneesh Modi
Portfolio Manager
Rick Whipple
Equity Client Portfolio Manager
Tony Yao
Portfolio Manager
Scott Kudrick
Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
